Alumis Inc. Files 8-K: Other Events & Financials
Ticker: ALMS · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing
TL;DR
Alumis Inc. filed an 8-K on 3/25/25. Check it out.
AI Summary
Alumis Inc. filed an 8-K on March 25, 2025, reporting other events and financial statements. The company, formerly Esker Therapeutics, Inc., is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing indicates Alumis Inc. is providing updates on its corporate activities and financial status, which is important for investors to monitor.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant corporate events or financial updates.
Key Players & Entities
- Alumis Inc. (company) — Registrant
- Esker Therapeutics, Inc. (company) — Former company name
- March 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- South San Francisco, California (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Alumis Inc.?
The filing reports 'Other Events' and 'Financial Statements and Exhibits' for Alumis Inc.
When was this 8-K report filed?
The report was filed on March 25, 2025.
What was Alumis Inc. previously known as?
Alumis Inc. was formerly known as Esker Therapeutics, Inc.
Where are Alumis Inc.'s principal executive offices located?
Alumis Inc.'s principal executive offices are located at 280 East Grand Avenue, South San Francisco, California 94080.
In which state is Alumis Inc. incorporated?
Alumis Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding ALUMIS INC. (ALMS).